Joseph Group Capital Management Has $1.70 Million Holdings in Invesco Pharmaceuticals ETF $PJP

Joseph Group Capital Management increased its holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 9.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,242 shares of the company’s stock after purchasing an additional 1,907 shares during the period. Joseph Group Capital Management owned approximately 0.74% of Invesco Pharmaceuticals ETF worth $1,697,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of PJP. DHJJ Financial Advisors Ltd. acquired a new stake in shares of Invesco Pharmaceuticals ETF in the second quarter worth about $28,000. AE Wealth Management LLC raised its stake in shares of Invesco Pharmaceuticals ETF by 21.5% in the 2nd quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock valued at $57,000 after acquiring an additional 127 shares in the last quarter. N.E.W. Advisory Services LLC acquired a new stake in Invesco Pharmaceuticals ETF in the 1st quarter worth approximately $75,000. Focus Partners Advisor Solutions LLC bought a new stake in Invesco Pharmaceuticals ETF during the first quarter worth approximately $208,000. Finally, Jones Financial Companies Lllp boosted its position in Invesco Pharmaceuticals ETF by 11.6% during the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock worth $210,000 after purchasing an additional 252 shares during the period.

Invesco Pharmaceuticals ETF Stock Down 0.5%

Shares of PJP stock opened at $96.90 on Monday. Invesco Pharmaceuticals ETF has a 12 month low of $72.25 and a 12 month high of $97.54. The company has a market cap of $277.13 million, a PE ratio of 15.59 and a beta of 0.50. The business’s 50 day moving average is $93.72 and its two-hundred day moving average is $86.54.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.